Name | Methoctramine hydrate |
---|---|
Synonyms | N,N'-bis[6-[(2-methoxyphenyl)methylamino]hexyl]octane-1,8-diamine,tetrahydrochloride |
Description | Methoctramine tetrahydrochloride is a potent and cardioselectivity antagonist of M2 muscarinic receptor. Methoctramine tetrahydrochloride can inhibit Muscarine-induced bradycardia in vivo[1][2][3]. |
---|---|
Related Catalog | |
Target |
M2 muscarinic receptor[1] |
In Vitro | Methoctramine tetrahydrochloride attenuates Acetylcholine (ACh)- and Arecaidine propargyl ester (APE)-induced increases in PG synthesis in a concentration-dependent manner[1]. Methoctramine (0.01-1 μM) tetrahydrochloride causes facilitation of contractions induced by both pre- and postganglionic nerve stimulation in the guinea-pig isolated, innervated tracheal tube preparation[2]. Methoctramine (≥10 μM) tetrahydrochloride reduces responses to both nerve stimulation and exogenous ACh[2]. |
In Vivo | Methoctramine (300 µg/kg; i.v.) tetrahydrochloride strongly inhibits the Methacholine- and Muscarine-induced bradycardia in the anaesthetized rat, respectively[3]. |
References |
Boiling Point | 681.9ºC at 760mmHg |
---|---|
Molecular Formula | C36H66Cl4N4O2 |
Molecular Weight | 728.74700 |
Flash Point | 316.7ºC |
Exact Mass | 726.39400 |
PSA | 66.58000 |
LogP | 11.99540 |
Vapour Pressure | 1.89E-18mmHg at 25°C |
Storage condition | 2-8°C |